Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2016, Article ID 8264140, 4 pages
http://dx.doi.org/10.1155/2016/8264140
Case Report

Metastatic Breast Carcinoma to the Prostate Gland

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA

Received 16 May 2016; Accepted 12 June 2016

Academic Editor: Ossama W. Tawfik

Copyright © 2016 Meghan E. Kapp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. F. Anderson, I. Jatoi, J. Tse, and P. S. Rosenberg, “Male breast cancer: a population-based comparison with female breast cancer,” Journal of Clinical Oncology, vol. 28, no. 2, pp. 232–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. American Cancer Society, Cancer Facts & Figures 2014, 2014.
  3. L. A. Brinton, M. B. Cook, V. McCormack et al., “Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results,” Journal of the National Cancer Institute, vol. 106, no. 3, Article ID djt465, 2014. View at Publisher · View at Google Scholar
  4. L. A. Brinton, T. J. Key, L. N. Kolonel et al., “Prediagnostic sex steroid hormones in relation to male breast cancer risk,” Journal of Clinical Oncology, vol. 33, no. 18, pp. 2041–2050, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Leone, A. O. Zwenger, J. Iturbe et al., “Prognostic factors in male breast cancer: a population-based study,” Breast Cancer Research and Treatment, vol. 156, no. 3, pp. 539–548, 2016. View at Publisher · View at Google Scholar
  6. H. Eggemann, A. Ignatov, B. J. Smith et al., “Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients,” Breast Cancer Research and Treatment, vol. 137, no. 2, pp. 465–470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Alvarado Cabrero, M. Carrera Álvarez, D. Pérez Montiel, and F. A. Tavassoli, “Metastases to the breast,” European Journal of Surgical Oncology, vol. 29, no. 10, pp. 854–855, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Carder, V. Speirs, J. Ramsdale, and M. R. J. Lansdown, “Expression of prostate specific antigen in male breast cancer,” Journal of Clinical Pathology, vol. 58, no. 1, pp. 69–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. R. Croft, S. L. Lathrop, R. M. Feddersen, and N. E. Joste, “Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma,” Archives of Pathology and Laboratory Medicine, vol. 129, no. 2, pp. 194–199, 2005. View at Google Scholar · View at Scopus
  10. T. A. Zein, R. Huben, W. Lane, J. E. Pontes, and L. S. Englander, “Secondary tumors of the prostate,” Journal of Urology, vol. 133, no. 4, pp. 615–616, 1985. View at Google Scholar · View at Scopus
  11. A. W. Bates and S. I. Baithun, “Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases,” Virchows Archiv, vol. 440, no. 4, pp. 392–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Roshni, T. M. Anoop, T. R. Preethi, G. Shubanshu, and A. L. Lijeesh, “Gastric adenocarcinoma with prostatic metastasis,” Journal of Gastric Cancer, vol. 14, no. 2, pp. 135–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. R. Youssef, L. Hunt, P. D. Meiring, D. R. Taraporewalla, R. Gupta, and M. J. James, “Metastasis of a cecal adenocarcinoma to the prostate five years after a right hemicolectomy: a case report,” Journal of Medical Case Reports, vol. 5, article 223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Yoo, J. H. Lee, E. K. Kim, Y. K. Hong, Y. Lee, and H. C. Jeong, “Prostatic metastasis of large cell neuroendocrine carcinoma of the lung,” Respirology, vol. 14, no. 5, pp. 772–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Madersbacher, G. Schatzl, M. Susani, and U. Maier, “Prostatic metastasis of a small cell lung cancer in a young male,” European Urology, vol. 26, no. 3, pp. 267–269, 1994. View at Google Scholar · View at Scopus
  16. R.-M. Fokt, A. Templeton, S. Gillessen, C. Öhlschlegel, and H.-P. Schmid, “Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib,” Urologia Internationalis, vol. 83, no. 1, pp. 122–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. O. C. Guler, N. Bal, and C. Onal, “Metachronous prostate metastasis of renal cell carcinoma: case report and review of the literature,” Clinical Genitourinary Cancer, vol. 14, no. 2, pp. e211–e213, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Z. Clark, S. Beriwal, D. J. Dabbs, and R. Bhargava, “Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas,” American Journal of Clinical Pathology, vol. 142, no. 1, pp. 64–71, 2014. View at Publisher · View at Google Scholar · View at Scopus